1. IBRUTINIB IN ASSOCIATION WITH R‐DHAP/OX FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMA: PRELIMINARY RESULTS OF THE BIBLOS PHASE IB LYSA STUDY. (June 2017) Authors: Bonnet, C.M.; Lamy, T.; Fruchart, C.; Legouill, S.; Gunzer, K.; Gastinne, T.; Jardin, F.; Karlin, L.; Houot, R.; Dupuis, J.; Tilly, H.; Salles, G. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. R‐CHOP +/‐RADIOTHERAPY IN NON‐BULKY LIMITED‐STAGE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): FINAL RESULTS OF THE PROSPECTIVE RANDOMIZED PHASE III 02‐03 TRIAL FROM THE LYSA/GOELAMS. (June 2017) Authors: Lamy, T.; Damaj, G.; Soubeyran, P.; Gyan, E.; Legouill, S.; Cartron, G.; Boubdallah, K.; Gressin, R.; Cornillon, J.; Banos, A.; Ledu, K.; Benchalal, M.; Moles, M.; Fleury, J.; Godmer, P.; Maisonneuve, H.; Deconninck, E.; Laribi, K.; Marolleau, J.; Tournilhac, O. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗